| 
				 
				The EU executive said its assessment, published on Saturday, was 
				wholly based on the information provided by governments in their 
				bidding war to host the two agencies, which will be forced to 
				relocate from Britain when it leaves the bloc. 
				 
				"It (the assessment) respects the member states' decision that 
				the criteria should be unweighted and does not provide a ranking 
				or shortlist of any kind," the Commission said in a statement. 
				 
				Nineteen member states have bid to host the European Medical 
				Agency (EMA) and eight want the European Banking Authority 
				(EBA). 
				 
				The final say on where to move the agencies rests with EU 
				leaders who will try to reach a deal at their next summit in 
				three weeks' time, with a final decisions a month later. 
				 
				Candidate cities will be appraised based on their ability to 
				have an office ready in time, their accessibility, the quality 
				of schools, healthcare and jobs for the families of staff, and 
				how disruptive the move would be. 
				 
				In their eagerness to host the agencies, some governments have 
				offered tax breaks or rent-free headquarters for the EU 
				institutions - a big break for the bloc's budget. 
				 
				However, the EU's need to ensure business continuity could clash 
				with another EU ambition - spreading the bloc's agencies more 
				evenly across Europe and giving newer, eastern member states a 
				chance to catch up. 
				 
				The EMA on Tuesday warned that it could lose more than 70 
				percent of its staff, making it unable to function, if 
				politicians pick an unpopular base for the London-based agency 
				once Britain leaves the European Union. 
				 
				Amsterdam, Barcelona or Vienna were the top three choices of 
				staff, according to a survey of around 900 of its workers. All 
				of those cities already host one or more EU agencies. 
				 
				The EMA has said it would take at least three years to recover 
				fully from the disruption to its operations. It sees retaining 
				staff as key to maintaining essential services such as new drug 
				approval and monitoring side effects. 
				 
				(Reporting by Alissa de Carbonnel; Editing by Andrew Bolton) 
				
			[© 2017 Thomson Reuters. All rights 
				reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
				   | 
				
				
				 |